Godrej Consumer Products has reported consolidated revenue growth in the high teens for Q1FY27, backed by strong high single-digit underlying volume growth (UVG). The company's earnings before interest, taxes, depreciation, and amortisation (EBITDA) is expected to exceed its double-digit guidance for the quarter, despite margins remaining under pressure due to exceptional cost increases. The strong performance has drawn positive responses from leading brokerages, with Morgan Stanley, Nomura, and Macquarie all maintaining their constructive ratings on the stock.

Q1FY27 Performance Highlights

The company's Q1FY27 results reflect strong momentum across its consolidated business, with revenue expanding at a high-teens rate, meaningfully ahead of its full-year guidance of double-digit revenue growth. Volume growth in the high single digits further underscores the demand traction the company has experienced during the quarter. The following table summarises the key performance indicators reported for Q1FY27:

Segment Performance

Growth was broad-based across categories and geographies. The Standalone business delivered double-digit revenue growth, underpinned by high-single-digit underlying volume growth. The Indonesia business delivered a meaningful step-up in performance, with mid-teens revenue growth on the back of double-digit underlying volume growth. The GAUM (Godrej Africa, USA, and Middle East) business delivered another exceptionally strong quarter, with extremely strong double-digit sales growth on the back of strong underlying volume growth in the teens.

Analyst Views and Target Prices

The Q1FY27 performance has reinforced analyst confidence in the company's growth trajectory. Morgan Stanley, Nomura, and Macquarie have each maintained their ratings and target prices following the quarterly update. The table below summarises the latest analyst recommendations:

Nomura noted that consolidated revenue is expected to grow 16–17% YoY on high-single-digit volume growth, with EBITDA growth likely above 14% YoY—both ahead of full-year guidance. Macquarie highlighted the double-digit India sales performance with high-single-digit volume growth and a bullish FY27 outlook, citing the potential to exceed guidance on select metrics.

Margin Challenges and FY27 Outlook

Despite the strong revenue trajectory, Godrej Consumer Products acknowledged margin challenges during the quarter due to significant volatility in costs on account of movement in crude prices and other raw materials. However, the company's EBITDA performance is anticipated to surpass its own guidance, reflecting effective cost management and operational resilience. Encouragingly, costs have begun to ease in the closing weeks of the quarter. Management expects margins to recover progressively through the year and remains firmly on track to deliver its guidance for the full year, with a strong likelihood to exceed the same in select metrics.

Godrej Consumer Products has granted 14,92,392 stock options to eligible employees under its Employees Stock Option Scheme 2024 (ESOS 2024). The Nomination and Remuneration Committee of the Board of Directors approved the grant on June 26, 2026, to incentivize long-term performance and align employee interests with the company’s strategic objectives. The options are available to select employees who are part of the global leadership team, with vesting contingent upon meeting specific performance conditions.

The exercise price for the stock options is fixed at ₹1 per share, which is the face value of the underlying equity shares. Each stock option is convertible into one equity share of Godrej Consumer Products Limited. The total number of shares covered by these options is 14,92,392. The scheme complies with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Vesting of the granted options is structured in two equal tranches. The first 50% of the eligible stock options will vest on June 30, 2030, while the remaining 50% will vest on June 30, 2031. The options can be exercised within six months from the respective vesting dates. Equity shares arising from the exercise of these options will rank pari-passu with existing equity shares from the date of allotment.

Key Details of ESOS 2024 Grant

The disclosure was made to the exchanges in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Tejal Jariwala, Company Secretary & Compliance Officer, signed the intimation on behalf of Godrej Consumer Products Limited.